diabetes mellitus (DM) and hyperuricaemia and increase the risk of early onset MI 3 .This global phenomenon of prematurity and severity suggests that the disease starts at an early age and has a malignant and progressive course 3 .
In the western population incidence of MI in the young is up to 5% as compared to 12-16% in Indians. In some studies in India the percentage of patients below the age of 45 years suffering from AMI is reported as high as 25-40% 4 ,5 .
Early onset MI is defined as cardiac events occurring before the age of 55 years in men and 65 years in women. In its severe form it happens below the age of 40 years in either sex 6 . Cutoff age of forty five years has been used in most studies to define young onset MI 7 .
clearance was taken from Departmental and central ethical review committee, BSMMU. A total 100 myocardial infarction subjects of both sexes were selected for the study; of which 50 were early onset myocardial infarction patients (age < 45 years) designated as case & rest 50 were late onset myocardial infarction patients (age > 60 years) designated as control.
5 ml fasting venous blood was collected from each subject with all aseptic precautions and allowed to clot at room temperature and then centrifuged for 10-15 minutes. The separated serum was stored at -35 0 C until used for estimation.
Lab Methods
Estimation of serum total cholesterol concentration:
Enzymatic end point (CHOD-PAP) method 8 .
Estimation of serum Triacylglycerol concentration:
Enzymatic colorimetric GPO-PAP method 9 .
Estimation of serum HDL-C concentration:
Enzymatic colorimetric phosphotungstate/ magnesium method 10 .
Calculation of LDL-C concentration:
Fried Wald formula 11 .
Results and Observations
The age and sex pattern is shown on 
Discussion
Present study showed the serum TC and TAG conc. significantly high in cases in comparison to control. This is well in line with the different studies done abroad. [12] [13] [14] [15] It is well known that 70% of circulating total cholesterol is carried by LDL particles. Increased TC in our cases inspite of similar LDL-C between cases & control might be due to the predominance of other cholesterol containing lipoproteins e.g. Very Low Density Lipoprotein (VLDL), Intermediate Density Lipoprotein (IDL) & chylomicron remnant which are highly atherogenic & could be incriminated for early onset MI. Hypertriglyceridaemia brings qualitative changes on LDL particles to make them small dense LDL which are more atherogenic but contain less cholesterol in comparison to other large LDL subtype. Probably there is predominance of small dense LDL in early onset MI, because of which with respect of LDL-C early & late onset MI patients found to be identical. Hypertriglyceridaemia also affects the HDL particles to be transformed into HDL 1 subtype which is claimed to be atherogenic or not antiatherogenic. So it is possible that relatively atherogenic HDL subtypes (HDL I ) are predominant in early onset MI because of which they manifest the disease in younger age in spite of normal HDL-cholesterol. Therefore This study showed no difference between cases and control with respect to HDL-C concentration inspite of high TAG concentration in cases. This finding clearly contradicts others 16, 17 . HDL particles are of two distinct subclass; one is small, dense, relatively cholesterol enrich HDL 1 containing both apo A-I & apo A-II which is suspected to be atherogenic or not antiatherogenic; another is large, buoyant, cholesterol poor HDL 2 containing only apo-A-I which is convincingly antiatherogenic 18 . Therefore the present picture of our study could probably be explained by the predominance of less atheroprotective or atherogenic HDL 1 in cases & antiatherogenic HDL 2 in control. Since HDL 2 is cholesterol poor relative to HDL 1 , so probably the number of HDL 2 particle is more in control compared to that of HDL 1 particle in cases since the HDL-C concentration is similar in both cases and control. The predominance of HDL 1 in cases explain the propensity of MI in younger age which our study has revealed. The traditional view of hypertriglyceridaemia leading to reduced HDL-C in fact points to the loss of atheroprotection. In our early onset MI patients probably there is loss atheroprotection due to the predominance of atherogenic HDL 1 although HDL-C concentration not that much reduced.
This study has revealed no significant difference between cases and control with respect to TC/HDL-C ratio & LDL-C/HDL-C ratio. When compared between cases & control both LDL-Cholesterol & HDLCholesterol showed no difference; that is why probably the LDL-C/HDL-C ratio also showed no difference between cases & control. Regarding the TC/HDL-C ratio it was expected to be higher in cases since the TC was higher in cases with HDL-C statistically identically between cases & control. In fact from the view point of numerical figures HDL-C also found higher in cases than control although it failed to reach the statistical significance. This could be the probable explanation of no significant difference of TC/HDL-C ratio between cases & control.
TAG/TC ratio in early onset MI of this study found significantly raised compared to late onset MI. In fact both TC & TAG were significantly higher in cases compared to control but disproportionately there was more raise of TAG compared TC with the consequential increased ratio of TAG/TC in cases. The numerical ratios of TAG/TC in cases & control of our study found 1.14 & 0.96 respectively. The ratio 1.14 indicates the Familial Combined Hyperlipidaemia (FCHL) rather than the isolated hypertriglyceridaemia. Austin & his co-workers in their 20 yr. prospective study proposed that there is 1.7-10 fold increased risk of premature CAD in FCHL. So the finding of FCHL in our cases of early onset MI seems to be befitting in light of the above mentioned prospective study. This study has revealed no significant difference between cases & control with respect to the non-HDL cholesterol. Since the majority of non-HDL-C is LDL-C & the LDL-C found identical in both case & control so is the picture of non-HDL cholesterol.
